acute asthma asthma exacerbation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -children 2-18 years of age admitted for acute asthma -treatment for acute asthma according to current dutch guideline -supplemental oxygen use, low flow or high flow
Exclusion criteria
Exclusion criteria: -severe acute asthma for which intravenous albuterol is indicated -unstable heart disease -cystic fbrosis or other chronich or congenital lung disease -any neurological disease -any muscular disease -developmental delay
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the difference in admission time for children with acute asthma who are treated according to the current nurse-driven pathway or the new pathway with adjusted treatment thresholds for patients who need supplemental oxygen. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are -number of bronchodilator adminstrations per patient, -the number of deviations from the pathway; administration of bronchodilators when not indicated or when bronchodilators were indicated but not administered. -number or assessments by attending physician -number of patients excluded because they needed treatment with intravenous albuterol -number of re-admission within one week -association between heart rate and the total CAS en individual items of CAS -difference between groups in administration of intravenous magensiumsulphate -difference between groups in transfer to pediatric intensive care unit | — |
Countries
Netherlands
Contacts
Martini Ziekenhuis